Blauvelt, A. , Wollenberg, A., Pink, A., Peris, K. , Armstrong , A., Spelman, L., Saeki, H., Lynde, C., Herranz, P., Barbarot, S. and Simpson, E. 2021. Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2). SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s57. DOI:https://doi.org/10.25251/skin.5.supp.57.